Pooled plasma (Human)

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NamePooled plasma (Human)
Drug Alias Name血浆蛋白组分Fresh frozen plasmaPlasma protein fraction (human)混合renleixuejiang经处理的混合人类血浆 +[6] 
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcquired thrombotic thrombocytopenic purpuraCoronavirus Disease 2019 (COVID-19)Liver Diseases +[5] 
Global Approved IndicationsAcquired thrombotic thrombocytopenic purpuraLiver Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/01/17
Country/TerritoryUnited StatesDenmarkUnited Kingdom
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOctapharma
China Registration ClassN/A

Develop Information

Active CompaniesUniversity College LondonUniversity Of Colorado Health
Inactive CompaniesOctapharma
Active IndicationsAcquired thrombotic thrombocytopenic purpuraCoronavirus Disease 2019 (COVID-19)Liver Diseases +[4] 
Inactive IndicationsShock, Septic

Other Information

ATC CodeB05AX03
Related LinksWikipediaDrugBank